Literature DB >> 33311000

Proposal of diagnostic criteria for IgG4-related thyroid disease.

Ken Takeshima1, Yaqiong Li2, Kennichi Kakudo3, Mitsuyoshi Hirokawa4, Eijun Nishihara5, Akira Shimatsu6,7, Yutaka Takahashi8, Takashi Akamizu1,5.   

Abstract

Patients with IgG4-related disease (IgG4-RD) are diagnosed in Japan by comprehensive or organ-specific diagnostic criteria. To date, organ-specific criteria have been established for several organs, but not for the thyroid. We attempted to establish diagnostic criteria for IgG4-related thyroid disease (IgG4-RTD) based on IgG4-RD research by The Research Program on Intractable Diseases from the Ministry of Health, Labour and Welfare of Japan. These criteria have been publicly reported to members of both the Japan Endocrine Society and the Japan Thyroid Association. Thyroid diseases associated with IgG4 include Hashimoto's thyroiditis, Graves' disease and Riedel's thyroiditis. As a comprehensive definition that includes both systematic and organ-specific forms, we use the broad term 'IgG4-related thyroid disease'. Diagnostic criteria for IgG4-RTD comprise the following five items: I) enlargement of the thyroid, II) hypoechoic lesions in the thyroid by ultrasonography, III) elevated serum IgG4 levels, IV) histopathological findings in the thyroid lesion (IgG4+ plasma cells >20/HPF and IgG4+/IgG+ plasma cell ratio >30%) and V) involvement of other organs. "Definitive" diagnosis of IgG4-RTD is made when I, II, III and IV are all fulfilled, while "probable" diagnosis of IgG4-RTD is when I, II, and IV or V are fulfilled. Patients who fulfill I, II and III criteria are considered as "possible" IgG4-RTD. We believe that the proposed diagnostic criteria contribute to more accurate diagnosis of IgG4-RTD as well as exclusion of mimicry. Furthermore, they may lead to better understanding of the clinical implications and underlying pathogenesis of IgG4-RTD.

Entities:  

Keywords:  Grave’s disease; Hashimoto’s thyroiditis; IgG4 thyroiditis; IgG4-related thyroid disease; Riedel’s thyroiditis

Year:  2020        PMID: 33311000     DOI: 10.1507/endocrj.EJ20-0557

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  5 in total

1.  Clinical features and treatment efficacy for IgG4-related thyroiditis.

Authors:  Xinxin Han; Panpan Zhang; Jieqiong Li; Zheng Liu; Hui Lu; Xuan Luo; Boju Pan; Xiaolan Lian; Xuejun Zeng; Wen Zhang; Xiaofeng Zeng
Journal:  Orphanet J Rare Dis       Date:  2021-07-21       Impact factor: 4.123

Review 2.  Immunoglobulin G4-related Disease: A New Systemic Disease Emerging in Japan.

Authors:  Terumi Kamisawa
Journal:  JMA J       Date:  2021-12-15

Review 3.  Immunoglobulin G4-Related Thyroid Disease: A Single-Center Experience and Literature Review.

Authors:  Meihua Jin; Bictdeun Kim; Ahreum Jang; Min Ji Jeon; Young Jun Choi; Yu-Mi Lee; Dong Eun Song; Won Gu Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2022-04-25

4.  Deterioration of pituitary function without relapse after steroid therapy for IgG4-related hypophysitis.

Authors:  Nobuyuki Nishi; Ken Takeshima; Shuhei Morita; Hiroshi Iwakura; Masahiro Nishi; Takaaki Matsuoka
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2021-07-01

Review 5.  IgG4 as a Biomarker in Graves' Orbitopathy.

Authors:  Michał Olejarz; Ewelina Szczepanek-Parulska; Daniela Dadej; Nadia Sawicka-Gutaj; Remigiusz Domin; Marek Ruchała
Journal:  Mediators Inflamm       Date:  2021-06-10       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.